219 related articles for article (PubMed ID: 17409608)
1. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
[TBL] [Abstract][Full Text] [Related]
6. Wegener's granulomatosis effectively treated with rituximab: a case study.
Kowalewska B; Szechiński J; Roszkowska E
Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
[TBL] [Abstract][Full Text] [Related]
7. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
8. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
9. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Stone JH; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Turkiewicz A; Tchao NK; Webber L; Ding L; Sejismundo LP; Mieras K; Weitzenkamp D; Ikle D; Seyfert-Margolis V; Mueller M; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh KA; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Specks U;
N Engl J Med; 2010 Jul; 363(3):221-32. PubMed ID: 20647199
[TBL] [Abstract][Full Text] [Related]
10. Rituximab induced remission in a patient with Wegener's granulomatosis.
Kallenbach M; Duan H; Ring T
Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
[TBL] [Abstract][Full Text] [Related]
11. Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case report.
Horai Y; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):105-10. PubMed ID: 20453447
[TBL] [Abstract][Full Text] [Related]
12. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
[No Abstract] [Full Text] [Related]
13. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
[TBL] [Abstract][Full Text] [Related]
14. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Viviano L; Ding L; Sejismundo LP; Mieras K; Iklé D; Jepson B; Mueller M; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh K; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Stone JH;
Arthritis Rheum; 2013 Sep; 65(9):2441-9. PubMed ID: 23754238
[TBL] [Abstract][Full Text] [Related]
16. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
Minami R; Miyamura T; Watanabe H; Takahama S; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):133-8. PubMed ID: 17473516
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment with rituximab in a refractory Wegener's granulomatosis with hypertrophic pachymeningitis and the right orbital granuloma].
Matsudaira R; Tamura N; Nawata M; Kaneda K; Takasaki Y
Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1464-6. PubMed ID: 17682433
[No Abstract] [Full Text] [Related]
20. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
